pk 11195 and dpa 714
pk 11195 has been researched along with dpa 714 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Ittner, LM; Kassiou, M; Scarf, AM | 1 |
| Da Pozzo, E; Damont, A; Dollé, F; Hanani, R; Hibbs, D; Kassiou, M; Martini, C; Reynolds, A; Selleri, S | 1 |
Reviews
1 review(s) available for pk 11195 and dpa 714
| Article | Year |
|---|---|
The translocator protein (18 kDa): central nervous system disease and drug design.
Topics: Acetamides; Apoptosis; Central Nervous System; Central Nervous System Diseases; Drug Design; Humans; Indoleacetic Acids; Indoles; Mitochondrial Membranes; Neurodegenerative Diseases; Phenyl Ethers; Pyrazoles; Pyrimidines; Receptors, GABA | 2009 |
Other Studies
1 other study(ies) available for pk 11195 and dpa 714
| Article | Year |
|---|---|
Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).
Topics: Acetamides; Animals; Carrier Proteins; Cell Line, Tumor; Ethers; Ligands; Pregnenolone; Protein Binding; Pyrazoles; Pyridines; Rats; Receptors, GABA-A | 2010 |